Eli Lilly with Evidation Health and Apple Report Results of Digital Alzheimer’s Study

 Eli Lilly with Evidation Health and Apple Report Results of Digital Alzheimer’s Study

Shots:

  • The study involves assessing of Apple devices (iPhone, Apple Watch, iPad and the Beddit sleep monitoring device) in combination with mobile applications in 113 candidates aged 60-70yrs. for 12wks. to identify cognitive & behavioral differences among the candidates with/out mild cognitive impairment or mild dementia related to Alzheimer’s
  • The study demonstrated that the wearable devices will help people to identify and indicate starting experiences of cognitive decline. Additionally, Apple devices & apps have the potential to test the efficacy of therapies, accelerate the development of therapies used in conjunction with traditional diagnostic tools to improve the accuracy of diagnoses
  • Evidation established a platform to obtain candidates’ consent, collecting and analyzing 16 terabytes of data from sensor data from the smart devices, questionnaires about mood & energy, and simple assessment activities on the Digital Assessment App

Click here to­ read full press release/ article | Ref: Eli Lilly | Image: Gizmodo

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post